Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ana H.C. Guimarães"'
Autor:
Melanie Hemmrich, Stephan Windecker, Ana Denise Zazula, George Dangas, Jan Tijssen, Usman Baber, Pascal Vranckx, Ana H.C. Guimarães, Marco Valgimigli, Roxana Mehran, Albert A. Volkl, Robert C. Welsh, Gerrit-Anne van Es, Karen Thomitzek, Gennaro Giustino, Peter Wildgoose
Publikováno v:
Windecker, Stephan; Tijssen, Jan; Giustino, Gennaro; Guimarães, Ana H C; Mehran, Roxana; Valgimigli, Marco; Vranckx, Pascal; Welsh, Robert C.; Baber, Usman; van Es, Gerrit-Anne; Wildgoose, Peter; Volkl, Albert A.; Zazula, Ana; Thomitzek, Karen; Hemmrich, Melanie; Dangas, George D. (2016). Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study. American Heart Journal, 184, pp. 81-87. Elsevier 10.1016/j.ahj.2016.10.017
American heart journal, 184, 81-87. Mosby Inc.
American heart journal, 184, 81-87. Mosby Inc.
Background Optimal antithrombotic treatment after transcatheter aortic valve replacement (TAVR) is unknown and determined empirically. The direct factor Xa inhibitor rivaroxaban may potentially reduce TAVR-related thrombotic complications and prematu
Autor:
Nancy Laurens, Ana H.C. Guimarães, Dingeman C. Rijken, Victor W.M. van Hinsbergh, Pieter Koolwijk, Ester M. Weijers
Publikováno v:
Arteriosclerosis Thrombosis & Vascular Biology, 27(10), 2157-2162. Lippincott Williams & Wilkins
Objective— Besides having a key role in fibrinolysis, the plasminogen system has been implicated in cell migration and angiogenesis. A common mechanism is the binding of plasminogen to carboxy-terminal lysine residues in partially degraded fibrin o